Moreover, myocardial fibrosis and TdT-mediated dUTP Nick-end labeling positive cardiomyocytes were markedly reduced in response to the treatment of rhMG53-S255A but not rhMG53-WT (Figure 7J and 7K; Figure S13). This evidence concerns the gene DNTT and Myocardial fibrosis.